首页 > 最新文献

Respiratory care最新文献

英文 中文
Transpulmonary Pressure as a Predictor of Successful Lung Recruitment: Reanalysis of a Multicenter International Randomized Clinical Trial.
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 DOI: 10.1089/respcare.11736
Abeer Santarisi, Aiman Suleiman, Simone Redaelli, Dario von Wedel, Jeremy R Beitler, Daniel Talmor, Valerie Goodspeed, Boris Jung, Maximilian S Schaefer, Elias Baedorf Kassis

Background: Recruitment maneuvers are used in patients with ARDS to enhance oxygenation and lung mechanics. Heterogeneous lung and chest-wall mechanics lead to unpredictable transpulmonary pressures and could impact recruitment maneuver success. Tailoring care based on individualized transpulmonary pressure might optimize recruitment, preventing overdistention. This study aimed to identify the optimal transpulmonary pressure for effective recruitment and to explore its association with baseline characteristics. Methods: We performed post hoc analysis on the Esophageal Pressure Guided Ventilation (EpVent2) trial. We estimated the dose-response relationship between end-recruitment end-inspiratory transpulmonary pressure and the change in lung elastance after a recruitment maneuver by using logistic regression weighted by a generalized propensity score. A positive change in lung elastance was indicative of overdistention. We examined how patient characteristics, disease severity markers, and respiratory parameters predict transpulmonary pressure by using multivariate linear regression models and dominance analyses. Results: Of 121 subjects, 43.8% had a positive change in lung elastance. Subjects with a positive change in lung elastance had a mean ± SD transpulmonary pressure of 15.1 ± 4.9 cm H2O, compared with 13.9 ± 3.9 cm H2O in those with a negative change in lung elastance. Higher transpulmonary pressure was associated with increased probability of a positive change in lung elastance (adjusted odds ratio 1.35 per 1 cm H2O of transpulmonary pressure, 95% CI 1.13-1.61; P = .001), which indicated an S-shaped dose-response curve, with overdistention probability > 50% at transpulmonary pressure values > 18.3 cm H2O. The volume of recruitment was transpulmonary pressure-dependent (P < .001; R2 = 0.49) and inversely related to a change in lung elastance after adjusting for baseline lung elastance (P < .001; R2 = 0.43). Negative correlations were observed between transpulmonary pressure and body mass index, PEEP, Sequential Organ Failure Assessment score, and PaO2/FIO2, whereas baseline lung elastance showed a positive correlation. The body mass index emerged as the dominant negative predictor of transpulmonary pressure (ranking 1; contribution to R2 = 0.08), whereas pre-recruitment elastance was the sole positive predictor (contribution to R2 = 0.06). Conclusions: Higher end-recruitment transpulmonary pressure increases the volume of recruitment but raises the risk of overdistention, providing the rationale for transpulmonary pressure to be used as a clinical target. Predictors, for example, body mass index, could guide recruitment maneuver individualization to balance adequate volume gain with overdistention.

{"title":"Transpulmonary Pressure as a Predictor of Successful Lung Recruitment: Reanalysis of a Multicenter International Randomized Clinical Trial.","authors":"Abeer Santarisi, Aiman Suleiman, Simone Redaelli, Dario von Wedel, Jeremy R Beitler, Daniel Talmor, Valerie Goodspeed, Boris Jung, Maximilian S Schaefer, Elias Baedorf Kassis","doi":"10.1089/respcare.11736","DOIUrl":"10.1089/respcare.11736","url":null,"abstract":"<p><p><b>Background:</b> Recruitment maneuvers are used in patients with ARDS to enhance oxygenation and lung mechanics. Heterogeneous lung and chest-wall mechanics lead to unpredictable transpulmonary pressures and could impact recruitment maneuver success. Tailoring care based on individualized transpulmonary pressure might optimize recruitment, preventing overdistention. This study aimed to identify the optimal transpulmonary pressure for effective recruitment and to explore its association with baseline characteristics. <b>Methods:</b> We performed post hoc analysis on the Esophageal Pressure Guided Ventilation (EpVent2) trial. We estimated the dose-response relationship between end-recruitment end-inspiratory transpulmonary pressure and the change in lung elastance after a recruitment maneuver by using logistic regression weighted by a generalized propensity score. A positive change in lung elastance was indicative of overdistention. We examined how patient characteristics, disease severity markers, and respiratory parameters predict transpulmonary pressure by using multivariate linear regression models and dominance analyses. <b>Results:</b> Of 121 subjects, 43.8% had a positive change in lung elastance. Subjects with a positive change in lung elastance had a mean ± SD transpulmonary pressure of 15.1 ± 4.9 cm H<sub>2</sub>O, compared with 13.9 ± 3.9 cm H<sub>2</sub>O in those with a negative change in lung elastance. Higher transpulmonary pressure was associated with increased probability of a positive change in lung elastance (adjusted odds ratio 1.35 per 1 cm H<sub>2</sub>O of transpulmonary pressure, 95% CI 1.13-1.61; <i>P</i> = .001), which indicated an S-shaped dose-response curve, with overdistention probability > 50% at transpulmonary pressure values > 18.3 cm H<sub>2</sub>O. The volume of recruitment was transpulmonary pressure-dependent (<i>P</i> < .001; R<sup>2</sup> = 0.49) and inversely related to a change in lung elastance after adjusting for baseline lung elastance (<i>P</i> < .001; R<sup>2</sup> = 0.43). Negative correlations were observed between transpulmonary pressure and body mass index, PEEP, Sequential Organ Failure Assessment score, and P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub>, whereas baseline lung elastance showed a positive correlation. The body mass index emerged as the dominant negative predictor of transpulmonary pressure (ranking 1; contribution to R<sup>2</sup> = 0.08), whereas pre-recruitment elastance was the sole positive predictor (contribution to R<sup>2</sup> = 0.06). <b>Conclusions:</b> Higher end-recruitment transpulmonary pressure increases the volume of recruitment but raises the risk of overdistention, providing the rationale for transpulmonary pressure to be used as a clinical target. Predictors, for example, body mass index, could guide recruitment maneuver individualization to balance adequate volume gain with overdistention.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"70 1","pages":"1-9"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11824879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Hospital-to-Home Transitional Care for COPD on Patient-Centered Outcomes.
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 DOI: 10.1089/respcare.11924
Yukyung Park, Woo Jin Kim, Seon Sook Han, Yeon Jeong Heo, Da Hye Moon, Ohbeom Kwon, Myung Goo Lee, Ji Young Hong, Chang Youl Lee, Yu Seong Hwang, Su Kyoung Kim, Heui Sug Jo

Background: Appropriate hospital-to-home transitional care has been recognized for its positive impact on health care usage and health outcomes in patients with COPD. However, there is limited research assessing its effects on patient-centered outcomes, focusing on patient symptoms and experiences. Methods: This single-blind randomized controlled trial included subjects diagnosed with COPD at one of 2 university hospitals in South Korea. The study included 179 subjects (transitional care group [transitional care], 87; usual care group [usual care], 92). The transitional care received transitional care comprising post-discharge care planning, personalized education, breathing exercises, telephone counseling, home visits, and referral to social services. We analyzed the effects of these interventions by comparing breathing symptoms and various patient-centered outcomes between the 2 groups. Results: The Modified Medical Research Council scores (mean [SD], transitional care 1.3 [1.06], usual care 1.82 [1.1], P = .002) and COPD Assessment Test scores (transitional care 6.32 [5.5], usual care 9.43 [7.16], P = .001) in the intervention group demonstrated more significant improvement than did those in the usual care. Following intervention, the subjects exhibited enhanced awareness of their disease, an increased frequency of inhaler use (transitional care 49.69 [1.67], usual care 46.86 [7.92], P = .002), and lower depression and anxiety scores. Additionally, the transitional care outperformed the usual care in the domain of subject experience during hospitalization (transitional care 39.34 [6.14], usual care 37.5 [5.61], P = .036), preparedness before discharge (transitional care 34.54 [4.96], usual care 32.3 [5.09], P = .003), and post-discharge management (transitional care 34.72 [4.36], usual care 30.29 [4.26], P = .003). Conclusions: Evidence-based transitional care services can exert positive effects on patient-centered indices. Our findings can be used as evidence of the need to establish patient-centered transitional care as a form of universal care for patients with COPD.

{"title":"Effect of Hospital-to-Home Transitional Care for COPD on Patient-Centered Outcomes.","authors":"Yukyung Park, Woo Jin Kim, Seon Sook Han, Yeon Jeong Heo, Da Hye Moon, Ohbeom Kwon, Myung Goo Lee, Ji Young Hong, Chang Youl Lee, Yu Seong Hwang, Su Kyoung Kim, Heui Sug Jo","doi":"10.1089/respcare.11924","DOIUrl":"https://doi.org/10.1089/respcare.11924","url":null,"abstract":"<p><p><b>Background:</b> Appropriate hospital-to-home transitional care has been recognized for its positive impact on health care usage and health outcomes in patients with COPD. However, there is limited research assessing its effects on patient-centered outcomes, focusing on patient symptoms and experiences. <b>Methods:</b> This single-blind randomized controlled trial included subjects diagnosed with COPD at one of 2 university hospitals in South Korea. The study included 179 subjects (transitional care group [transitional care], 87; usual care group [usual care], 92). The transitional care received transitional care comprising post-discharge care planning, personalized education, breathing exercises, telephone counseling, home visits, and referral to social services. We analyzed the effects of these interventions by comparing breathing symptoms and various patient-centered outcomes between the 2 groups. <b>Results:</b> The Modified Medical Research Council scores (mean [SD], transitional care 1.3 [1.06], usual care 1.82 [1.1], <i>P</i> = .002) and COPD Assessment Test scores (transitional care 6.32 [5.5], usual care 9.43 [7.16], <i>P</i> = .001) in the intervention group demonstrated more significant improvement than did those in the usual care. Following intervention, the subjects exhibited enhanced awareness of their disease, an increased frequency of inhaler use (transitional care 49.69 [1.67], usual care 46.86 [7.92], <i>P</i> = .002), and lower depression and anxiety scores. Additionally, the transitional care outperformed the usual care in the domain of subject experience during hospitalization (transitional care 39.34 [6.14], usual care 37.5 [5.61], <i>P</i> = .036), preparedness before discharge (transitional care 34.54 [4.96], usual care 32.3 [5.09], <i>P</i> = .003), and post-discharge management (transitional care 34.72 [4.36], usual care 30.29 [4.26], <i>P</i> = .003). <b>Conclusions:</b> Evidence-based transitional care services can exert positive effects on patient-centered indices. Our findings can be used as evidence of the need to establish patient-centered transitional care as a form of universal care for patients with COPD.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"70 1","pages":"81-91"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Parental Perspectives and Experiences With the Use of a Home Mechanical Insufflation-Exsufflation Device.
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2025-01-01 DOI: 10.1089/respcare.11689
Carolyn Jarock, Jordan Sheriko, Karen Hurtubise

Background: A mechanical insufflation-exsufflation (MI-E) device is a commonly used tool for airway clearance in children with an ineffective cough. Whereas the device has been shown to have multiple benefits, limited evidence exists regarding parents' experiences with its home use in the Canadian context. This study's objective was to explore the perspectives and experiences of parents who receive service through the IWK Health Centre and use an MI-E device at home with their child. Methods: The study used an interpretive description design. Semi-structured interviews, conducted with 9 participants, were audio recorded and transcribed verbatim. Transcripts were analyzed using a reflective thematic process. Results: Seven mothers and 2 fathers were interviewed. Following analysis, 3 themes were identified: (1) Learning about the MI-E device described participants' journey from becoming aware of the device to acquiring knowledge and skills about its use; (2) using the device detailed the integral role the MI-E device played in their lives, including decisions around use, and parental role; and (3) changing lives outlined the physical, emotional, and social benefits the device provided to the child and their family. Conclusions: Participants provided detailed descriptions of their journey from learning to integrating the MI-E device into their child's daily routine and family life. Its multiple associated benefits improved the child's and their family's quality of life. However, better education on its use was highlighted as a need for both parents and the health care professionals who work with them.

{"title":"Exploring the Parental Perspectives and Experiences With the Use of a Home Mechanical Insufflation-Exsufflation Device.","authors":"Carolyn Jarock, Jordan Sheriko, Karen Hurtubise","doi":"10.1089/respcare.11689","DOIUrl":"10.1089/respcare.11689","url":null,"abstract":"<p><p><b>Background:</b> A mechanical insufflation-exsufflation (MI-E) device is a commonly used tool for airway clearance in children with an ineffective cough. Whereas the device has been shown to have multiple benefits, limited evidence exists regarding parents' experiences with its home use in the Canadian context. This study's objective was to explore the perspectives and experiences of parents who receive service through the IWK Health Centre and use an MI-E device at home with their child. <b>Methods:</b> The study used an interpretive description design. Semi-structured interviews, conducted with 9 participants, were audio recorded and transcribed verbatim. Transcripts were analyzed using a reflective thematic process. <b>Results:</b> Seven mothers and 2 fathers were interviewed. Following analysis, 3 themes were identified: (1) <i>Learning about the MI-E device</i> described participants' journey from becoming aware of the device to acquiring knowledge and skills about its use; (2) <i>using the device</i> detailed the integral role the MI-E device played in their lives, including decisions around use, and parental role; and (3) <i>changing lives</i> outlined the physical, emotional, and social benefits the device provided to the child and their family. <b>Conclusions:</b> Participants provided detailed descriptions of their journey from learning to integrating the MI-E device into their child's daily routine and family life. Its multiple associated benefits improved the child's and their family's quality of life. However, better education on its use was highlighted as a need for both parents and the health care professionals who work with them.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"70 1","pages":"48-55"},"PeriodicalIF":2.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11824876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventilation Monitoring Using a Noninvasive Bioelectrical Impedance Device in Critically Ill Children. 使用无创生物电阻抗设备对重症儿童进行通气监测
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-11-19 DOI: 10.4187/respcare.12341
Andrew G Miller, Jordan Pung, Karan R Kumar, Alexandre T Rotta
{"title":"Ventilation Monitoring Using a Noninvasive Bioelectrical Impedance Device in Critically Ill Children.","authors":"Andrew G Miller, Jordan Pung, Karan R Kumar, Alexandre T Rotta","doi":"10.4187/respcare.12341","DOIUrl":"10.4187/respcare.12341","url":null,"abstract":"","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory Therapy Leaders' Perceptions of Value of Respiratory Care Services. 呼吸治疗领导者对呼吸护理服务价值的看法。
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-11-19 DOI: 10.4187/respcare.12144
Andrew G Miller, Katlyn L Burr, John S Emberger, Carl R Hinkson, Cheryl A Hoerr, Jerin Juby, Karsten J Roberts, Brian J Smith, Shawna L Strickland, Kyle J Rehder

Background: Respiratory care departments are experiencing an increased need to demonstrate value in the care they deliver. Value efficiency is a concept that incorporates the value of individual treatments into the normal operations of a department. The purpose of this study was to describe respiratory care leaders' attitudes about the value of services provided by respiratory care departments.

Methods: An electronic survey was distributed via social media, professional networks, and a manager work group. The survey was targeted to directors, managers, and supervisors of respiratory care departments. We asked questions related to value, services, and barriers to implementation of value efficiency. Data analysis was descriptive.

Results: We received 116 responses; 86% were from managers or directors. The 5 most valuable services delivered were invasive mechanical ventilation (82%), noninvasive ventilation or CPAP (71%), protocol-driven care (47%), code team (44%), and rapid response team (41%). The 5 least valuable services delivered by respiratory care departments were electrocardiograms (63%), stress testing (44%), lung expansion therapies (41%), sleep studies staffed by the respiratory care department (36%), and smoking cessation education (36%). The primary barrier to value efficiency was physician prescribing practices (68%). There was general agreement that physicians support respiratory therapy protocols (71%), value should be considered when evaluating respiratory care services (95%), and directing resources to more valuable services if possible (73%). Respondents did not agree that hospital administrators understand respiratory therapy workflow and full-time equivalent needs (35%) nor that hospital administrators would be supportive if we reduced services (18%).

Conclusions: In a small sample of respiratory therapy leaders, there was limited consensus on what respiratory care services are the most and least valuable. Lack of consensus on high- and low-value services and physician prescribing practice were the primary barriers to value efficiency. Nearly all respondents felt value should be considered when evaluating respiratory care services.

背景:呼吸护理部门越来越需要在其提供的护理服务中体现价值。价值效率是一个将单项治疗的价值纳入科室正常运营的概念。本研究旨在描述呼吸科领导者对呼吸科所提供服务价值的态度:方法:通过社交媒体、专业网络和经理工作小组分发电子调查问卷。调查对象为呼吸护理部的主任、经理和主管。我们提出了与价值、服务和实施价值效率的障碍相关的问题。数据分析为描述性分析:我们共收到 116 份回复,其中 86% 来自经理或主任。最有价值的 5 项服务是有创机械通气(82%)、无创通气或 CPAP(71%)、协议驱动护理(47%)、代码团队(44%)和快速反应团队(41%)。由呼吸科提供的价值最低的 5 项服务是心电图(63%)、压力测试(44%)、肺扩张疗法(41%)、由呼吸科人员进行的睡眠研究(36%)和戒烟教育(36%)。影响价值效率的主要障碍是医生的处方做法(68%)。受访者普遍认为,医生支持呼吸治疗方案(71%),评估呼吸护理服务时应考虑价值(95%),并尽可能将资源用于更有价值的服务(73%)。受访者不同意医院管理者了解呼吸治疗工作流程和全职等同需求(35%),也不同意如果我们减少服务,医院管理者会给予支持(18%):结论:在呼吸治疗领导者的小样本中,对于哪些呼吸治疗服务最有价值和最无价值的共识有限。对高价值和低价值服务缺乏共识以及医生开处方的做法是提高价值效率的主要障碍。几乎所有受访者都认为在评估呼吸治疗服务时应考虑价值。
{"title":"Respiratory Therapy Leaders' Perceptions of Value of Respiratory Care Services.","authors":"Andrew G Miller, Katlyn L Burr, John S Emberger, Carl R Hinkson, Cheryl A Hoerr, Jerin Juby, Karsten J Roberts, Brian J Smith, Shawna L Strickland, Kyle J Rehder","doi":"10.4187/respcare.12144","DOIUrl":"10.4187/respcare.12144","url":null,"abstract":"<p><strong>Background: </strong>Respiratory care departments are experiencing an increased need to demonstrate value in the care they deliver. Value efficiency is a concept that incorporates the value of individual treatments into the normal operations of a department. The purpose of this study was to describe respiratory care leaders' attitudes about the value of services provided by respiratory care departments.</p><p><strong>Methods: </strong>An electronic survey was distributed via social media, professional networks, and a manager work group. The survey was targeted to directors, managers, and supervisors of respiratory care departments. We asked questions related to value, services, and barriers to implementation of value efficiency. Data analysis was descriptive.</p><p><strong>Results: </strong>We received 116 responses; 86% were from managers or directors. The 5 most valuable services delivered were invasive mechanical ventilation (82%), noninvasive ventilation or CPAP (71%), protocol-driven care (47%), code team (44%), and rapid response team (41%). The 5 least valuable services delivered by respiratory care departments were electrocardiograms (63%), stress testing (44%), lung expansion therapies (41%), sleep studies staffed by the respiratory care department (36%), and smoking cessation education (36%). The primary barrier to value efficiency was physician prescribing practices (68%). There was general agreement that physicians support respiratory therapy protocols (71%), value should be considered when evaluating respiratory care services (95%), and directing resources to more valuable services if possible (73%). Respondents did not agree that hospital administrators understand respiratory therapy workflow and full-time equivalent needs (35%) nor that hospital administrators would be supportive if we reduced services (18%).</p><p><strong>Conclusions: </strong>In a small sample of respiratory therapy leaders, there was limited consensus on what respiratory care services are the most and least valuable. Lack of consensus on high- and low-value services and physician prescribing practice were the primary barriers to value efficiency. Nearly all respondents felt value should be considered when evaluating respiratory care services.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"respcare12144"},"PeriodicalIF":2.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Disparities in Pediatric Asthma.
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-11-19 DOI: 10.4187/respcare.12393
Juan C Celedón

In the United States, minoritized and marginalized groups such as non-Hispanic Black children, Puerto Rican children, American Indian/Alaska Native children, and multiracial children share a disproportionate burden of asthma, largely because of greater exposure to environmental, lifestyle, and behavioral risk factors than white children. Such unequal exposure is due to racism and discriminatory policies that affect social determinants of health and, ultimately, area of residence and access to resources. In this focused article, I first review the epidemiology and selected risk factors for health disparities in asthma and then briefly discuss knowledge gaps and future directions in this field. Except for genetics, risk factors for disparities in asthma and poor asthma outcomes are potentially modifiable and co-exist at the individual or community level, including exposure to violence and related distress; indoor and outdoor pollutants; unhealthy dietary habits; overweight or obesity; and barriers to adequate health care, such as lack of health insurance and poor parental health literacy. Research plays an important role in advancing our knowledge of the determinants and prevention of health disparities in asthma but should not preclude the development and implementation of policies that foster funding of inclusive research studies and clinical trials, "environmental justice," and universal health care. Advocating for such policies requires concerted efforts by all key stakeholders to achieve better health outcomes for all children with asthma.

{"title":"Health Disparities in Pediatric Asthma.","authors":"Juan C Celedón","doi":"10.4187/respcare.12393","DOIUrl":"https://doi.org/10.4187/respcare.12393","url":null,"abstract":"<p><p>In the United States, minoritized and marginalized groups such as non-Hispanic Black children, Puerto Rican children, American Indian/Alaska Native children, and multiracial children share a disproportionate burden of asthma, largely because of greater exposure to environmental, lifestyle, and behavioral risk factors than white children. Such unequal exposure is due to racism and discriminatory policies that affect social determinants of health and, ultimately, area of residence and access to resources. In this focused article, I first review the epidemiology and selected risk factors for health disparities in asthma and then briefly discuss knowledge gaps and future directions in this field. Except for genetics, risk factors for disparities in asthma and poor asthma outcomes are potentially modifiable and co-exist at the individual or community level, including exposure to violence and related distress; indoor and outdoor pollutants; unhealthy dietary habits; overweight or obesity; and barriers to adequate health care, such as lack of health insurance and poor parental health literacy. Research plays an important role in advancing our knowledge of the determinants and prevention of health disparities in asthma but should not preclude the development and implementation of policies that foster funding of inclusive research studies and clinical trials, \"environmental justice,\" and universal health care. Advocating for such policies requires concerted efforts by all key stakeholders to achieve better health outcomes for all children with asthma.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"respcare12393"},"PeriodicalIF":2.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143449788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Positive Expiratory Pressure Device on Gas Exchange, Atelectasis, Hemodynamics, and Dyspnea in Spontaneously Breathing Critically Ill Subjects. 正呼气压力装置对自主呼吸危重症患者的气体交换、肺不张、血液动力学和呼吸困难的影响
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-11-19 DOI: 10.4187/respcare.12000
Denise Masuello, Adriano Servetti, Salvatore Caiffa, Robertina Cara, Chiara Pieri, Ricardo Arriagada, Lou'i Al-Husinat, Lorenzo Ball, Chiara Robba, Iole Brunetti, Nicolò Patroniti, Pedro Leme Silva, Patricia Rm Rocco, Denise Battaglini

Background: EzPAP Positive Airway Pressure System (EzPAP) is a noninvasive positive expiratory pressure (PEP) device designed to promote lung expansion. The aim of this study was to evaluate the effects of PEP on gas exchange. Secondary objectives included assessing the early effects of PEP on radiological atelectasis score (RAS), hemodynamics, and dyspnea. These outcomes were compared between spontaneously breathing subjects with and without tracheostomy.

Methods: This observational single-center study was conducted at a university hospital. Inclusion criteria were spontaneously breathing adult subjects with RAS ≥ 2 and a worsened PaO2/FIO2. Exclusion criteria included life-threatening conditions, intracranial hypertension, hemodynamic instability, and pneumothorax. Gas-exchange, hemodynamic parameters, and dyspnea measured with the Respiratory Distress Observation Scale (RDOS) were assessed at 3 time points: T0 (before PEP), T1 (immediately after PEP), and T2 (2 h after PEP). RAS was assessed at T0 and 1-week post treatment (T3).

Results: Of 213 patients assessed for eligibility, 186 were excluded for various reasons, leaving 27 subjects (19 without and 8 with tracheostomy) enrolled in the study. The median [interquartile range] age was 65 [58-74] y, with 66.7% being male. In the overall sample and in subjects without tracheostomy, PaO2/FIO2 did not differ significantly between T1 and T0 (P = .52 and P = .54, respectively) or between T2 and T0 (P = .47 and P = .85, respectively). In subjects with tracheostomy, PaO2/FIO2was higher at T1 compared to T0 (P = .039) but not between T2 and T0 (P = .58). Arterial PaO2 and hemodynamic parameters remained unchanged in the overall cohort. The RAS improved within 1 week of treatment in the overall cohort (T3 vs T0, P < .001) and in subjects without tracheostomy (T3 vs T0, P = .001). However, PEP therapy did not improve RDOS.

Conclusions: In critically ill, spontaneously breathing subjects, PEP therapy significantly improved RAS without affecting hemodynamic stability or respiratory symptoms.

背景:EzPAP 气道正压系统(EzPAP)是一种无创呼气正压(PEP)设备,旨在促进肺扩张。本研究旨在评估 PEP 对气体交换的影响。次要目标包括评估 PEP 对放射学肺不张评分 (RAS)、血液动力学和呼吸困难的早期影响。这些结果将在有气管造口术和无气管造口术的自主呼吸受试者之间进行比较:这项观察性单中心研究在一家大学医院进行。纳入标准为 RAS ≥ 2 且 PaO2 /FIO2 恶化的自主呼吸成人受试者。排除标准包括危及生命的情况、颅内高压、血流动力学不稳定和气胸。在 3 个时间点对气体交换、血液动力学参数和呼吸窘迫观察量表(RDOS)测量的呼吸困难进行评估:T0(PEP 前)、T1(PEP 后立即)和 T2(PEP 后 2 小时)。RAS在T0和治疗后一周(T3)进行评估:在接受资格评估的 213 名患者中,有 186 人因各种原因被排除在外,剩下 27 名受试者(19 人未做气管造口术,8 人做了气管造口术)参加了研究。中位数[四分位数间距]年龄为65[58-74]岁,66.7%为男性。在总体样本和未实施气管造口术的受试者中,PaO2 /FIO2 在 T1 和 T0 之间(分别为 P = .52 和 P = .54)或 T2 和 T0 之间(分别为 P = .47 和 P = .85)没有显著差异。在气管切开的受试者中,T1 时的 PaO2 /FIO2 比 T0 时高(P = .039),但在 T2 和 T0 之间没有差异(P = .58)。整个组群的动脉 PaO2 和血液动力学参数保持不变。在整个组群中,RAS 在治疗后 1 周内得到改善(T3 vs T0,P < .001),在没有气管造口术的受试者中也得到改善(T3 vs T0,P = .001)。然而,PEP疗法并未改善RDOS:结论:在重症自主呼吸患者中,PEP疗法可显著改善RAS,而不会影响血液动力学稳定性或呼吸系统症状。
{"title":"Effects of Positive Expiratory Pressure Device on Gas Exchange, Atelectasis, Hemodynamics, and Dyspnea in Spontaneously Breathing Critically Ill Subjects.","authors":"Denise Masuello, Adriano Servetti, Salvatore Caiffa, Robertina Cara, Chiara Pieri, Ricardo Arriagada, Lou'i Al-Husinat, Lorenzo Ball, Chiara Robba, Iole Brunetti, Nicolò Patroniti, Pedro Leme Silva, Patricia Rm Rocco, Denise Battaglini","doi":"10.4187/respcare.12000","DOIUrl":"10.4187/respcare.12000","url":null,"abstract":"<p><strong>Background: </strong>EzPAP Positive Airway Pressure System (EzPAP) is a noninvasive positive expiratory pressure (PEP) device designed to promote lung expansion. The aim of this study was to evaluate the effects of PEP on gas exchange. Secondary objectives included assessing the early effects of PEP on radiological atelectasis score (RAS), hemodynamics, and dyspnea. These outcomes were compared between spontaneously breathing subjects with and without tracheostomy.</p><p><strong>Methods: </strong>This observational single-center study was conducted at a university hospital. Inclusion criteria were spontaneously breathing adult subjects with RAS ≥ 2 and a worsened P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub>. Exclusion criteria included life-threatening conditions, intracranial hypertension, hemodynamic instability, and pneumothorax. Gas-exchange, hemodynamic parameters, and dyspnea measured with the Respiratory Distress Observation Scale (RDOS) were assessed at 3 time points: T0 (before PEP), T1 (immediately after PEP), and T2 (2 h after PEP). RAS was assessed at T0 and 1-week post treatment (T3).</p><p><strong>Results: </strong>Of 213 patients assessed for eligibility, 186 were excluded for various reasons, leaving 27 subjects (19 without and 8 with tracheostomy) enrolled in the study. The median [interquartile range] age was 65 [58-74] y, with 66.7% being male. In the overall sample and in subjects without tracheostomy, P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub> did not differ significantly between T1 and T0 (<i>P</i> = .52 and <i>P</i> = .54, respectively) or between T2 and T0 (<i>P</i> = .47 and <i>P</i> = .85, respectively). In subjects with tracheostomy, P<sub>aO<sub>2</sub></sub>/F<sub>IO<sub>2</sub></sub>was higher at T1 compared to T0 (<i>P</i> = .039) but not between T2 and T0 (<i>P</i> = .58). Arterial P<sub>aO<sub>2</sub></sub> and hemodynamic parameters remained unchanged in the overall cohort. The RAS improved within 1 week of treatment in the overall cohort (T3 vs T0, <i>P</i> < .001) and in subjects without tracheostomy (T3 vs T0, <i>P</i> = .001). However, PEP therapy did not improve RDOS.</p><p><strong>Conclusions: </strong>In critically ill, spontaneously breathing subjects, PEP therapy significantly improved RAS without affecting hemodynamic stability or respiratory symptoms.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"respcare12000"},"PeriodicalIF":2.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142676746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editor's Commentary. 编辑评论。
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-11-18
{"title":"Editor's Commentary.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"69 12","pages":"i"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disability Following Critical Illness Due to COVID-19-Where to Next? COVID-19 导致重病后残疾--下一步该怎么办?
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-11-18 DOI: 10.4187/respcare.12605
Luke A McDonald, Thomas C Rollinson
{"title":"Disability Following Critical Illness Due to COVID-19-Where to Next?","authors":"Luke A McDonald, Thomas C Rollinson","doi":"10.4187/respcare.12605","DOIUrl":"10.4187/respcare.12605","url":null,"abstract":"","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":"69 12","pages":"1614-1616"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaptive Pressure Control-Continuous Mandatory Ventilation Versus Volume Control-Continuous Mandatory Ventilation: Factors Associated With Initiation, Maintenance, and Adjustment. 自适应压力控制-连续强制通气与容量控制-连续强制通气:与启动、维持和调整相关的因素。
IF 2.4 4区 医学 Q2 CRITICAL CARE MEDICINE Pub Date : 2024-11-18 DOI: 10.4187/respcare.11430
Linh N Tran, Jared E Rosen, Alex K Pearce, Atul Malhotra, Russell G Buhr, Ragan Saggar, Jeffrey A Davis, Jennifer L Martin, Biren B Kamdar

Background: Adaptive pressure control-continuous mandatory ventilation (APC-CMV) is a frequently utilized ventilator mode in ICU settings. This analysis compared APC-CMV and traditional volume control-continuous mandatory ventilation (VC-CMV) mode, describing factors associated with initiation, maintenance, and changes in settings of each mode.

Methods: We analyzed ventilator data from a retrospective electronic health record data set collected as part of a quality improvement project in a single academic ICU. The majority ventilator mode was defined as the mode comprising the highest proportion of mechanical ventilation time. Multivariable logistic regression was used to identify variables associated with initial and majority APC-CMV or VC-CMV modes. Wilcoxon rank-sum tests were used to compare ventilator setting changes/d and sedation as a function of APC-CMV and VC-CMV majority modes.

Results: Among 1,213 subjects initiated on mechanical ventilation from January 2013-March 2017, 68% and 24% were initiated on APC-CMV and VC-CMV, respectively, which composed 62% and 21% of the majority ventilator modes. Age, sex, race, and ethnicity were not associated with the initial or majority APC-CMV or VC-CMV modes. Subjects initiated on APC-CMV spent 88% of the mechanical ventilation time on APC-CMV mode. Compared to VC-CMV, subjects with APC-CMV majority mode experienced more ventilator setting changes/d (1.1 vs 0.8, P < .001). There were no significant differences in sedative medications when comparing subjects receiving APC-CMV versus VC-CMV majority modes.

Conclusions: APC-CMV was highly utilized in the medical ICU. Subjects on APC-CMV had more ventilator setting changes/d than those on VC-CMV. APC-CMV offered no advantage of reduced setting adjustments or less sedation compared to VC-CMV.

背景:自适应压力控制-持续强制通气(APC-CMV)是 ICU 环境中经常使用的一种呼吸机模式。本分析比较了 APC-CMV 和传统的容量控制-持续强制通气(VC-CMV)模式,描述了与每种模式的启动、维持和设置更改相关的因素:我们分析了在一家学术重症监护室中作为质量改进项目一部分收集的回顾性电子健康记录数据集中的呼吸机数据。大多数呼吸机模式被定义为占机械通气时间比例最高的模式。多变量逻辑回归用于确定与初始和多数 APC-CMV 或 VC-CMV 模式相关的变量。使用 Wilcoxon 秩和检验比较呼吸机设置变化/d 和镇静与 APC-CMV 和 VC-CMV 多数模式的关系:在 2013 年 1 月至 2017 年 3 月期间开始使用机械通气的 1213 名受试者中,分别有 68% 和 24% 开始使用 APC-CMV 和 VC-CMV,这两种通气模式分别占大多数通气模式的 62% 和 21%。年龄、性别、种族和民族与初始或大多数 APC-CMV 或 VC-CMV 模式无关。开始使用 APC-CMV 的受试者有 88% 的机械通气时间是在 APC-CMV 模式下度过的。与 VC-CMV 相比,使用 APC-CMV 多数模式的受试者经历了更多的呼吸机设置变化/天(1.1 vs 0.8,P < .001)。在使用镇静药物方面,APC-CMV 与 VC-CMV 多数模式的受试者没有明显差异:结论:APC-CMV在内科重症监护室的使用率很高。与使用 VC-CMV 的受试者相比,使用 APC-CMV 的受试者有更多的呼吸机设置变化/d。与 VC-CMV 相比,APC-CMV 在减少设置调整或减少镇静方面没有优势。
{"title":"Adaptive Pressure Control-Continuous Mandatory Ventilation Versus Volume Control-Continuous Mandatory Ventilation: Factors Associated With Initiation, Maintenance, and Adjustment.","authors":"Linh N Tran, Jared E Rosen, Alex K Pearce, Atul Malhotra, Russell G Buhr, Ragan Saggar, Jeffrey A Davis, Jennifer L Martin, Biren B Kamdar","doi":"10.4187/respcare.11430","DOIUrl":"10.4187/respcare.11430","url":null,"abstract":"<p><strong>Background: </strong>Adaptive pressure control-continuous mandatory ventilation (APC-CMV) is a frequently utilized ventilator mode in ICU settings. This analysis compared APC-CMV and traditional volume control-continuous mandatory ventilation (VC-CMV) mode, describing factors associated with initiation, maintenance, and changes in settings of each mode.</p><p><strong>Methods: </strong>We analyzed ventilator data from a retrospective electronic health record data set collected as part of a quality improvement project in a single academic ICU. The majority ventilator mode was defined as the mode comprising the highest proportion of mechanical ventilation time. Multivariable logistic regression was used to identify variables associated with initial and majority APC-CMV or VC-CMV modes. Wilcoxon rank-sum tests were used to compare ventilator setting changes/d and sedation as a function of APC-CMV and VC-CMV majority modes.</p><p><strong>Results: </strong>Among 1,213 subjects initiated on mechanical ventilation from January 2013-March 2017, 68% and 24% were initiated on APC-CMV and VC-CMV, respectively, which composed 62% and 21% of the majority ventilator modes. Age, sex, race, and ethnicity were not associated with the initial or majority APC-CMV or VC-CMV modes. Subjects initiated on APC-CMV spent 88% of the mechanical ventilation time on APC-CMV mode. Compared to VC-CMV, subjects with APC-CMV majority mode experienced more ventilator setting changes/d (1.1 vs 0.8, <i>P</i> < .001). There were no significant differences in sedative medications when comparing subjects receiving APC-CMV versus VC-CMV majority modes.</p><p><strong>Conclusions: </strong>APC-CMV was highly utilized in the medical ICU. Subjects on APC-CMV had more ventilator setting changes/d than those on VC-CMV. APC-CMV offered no advantage of reduced setting adjustments or less sedation compared to VC-CMV.</p>","PeriodicalId":21125,"journal":{"name":"Respiratory care","volume":" ","pages":"1491-1498"},"PeriodicalIF":2.4,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141898079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Respiratory care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1